人乳头瘤病毒疫苗接种与首次性行为年龄，美国国家健康与营养检查调查
Human Papillomavirus Vaccination and Age at First Sexual Activity, National Health and Nutrition Examination Survey.
作者信息
Petrosky Emiko Y, Liu Gui, Hariri Susan, Markowitz Lauri E
机构信息
1 National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
出版信息
Clin Pediatr (Phila). 2017 Apr;56(4):363-370. doi: 10.1177/0009922816660541. Epub 2016 Oct 1.
Abstract
The National Health and Nutrition Examination Survey (NHANES) collects information on human papillomavirus (HPV) vaccination history as well as sexual activity. We evaluated data from NHANES to assess report of HPV vaccination with ≥1 dose and 3 doses among females and males aged 11 to 26 years during 2007-2014. We also examined age at first vaccine dose and age at first sexual activity among females aged 14 to 26 years. Vaccination significantly increased in females aged 13 to 26 years, but not among 11- to 12-year-old girls, and remained low for both females and males. In NHANES 2011-2014, among females with known age at first vaccine dose, 43.1% reported having had sex before or in the same year they received their first HPV vaccine, and this varied by race/ethnicity. Clinicians should provide strong recommendations consistent with guidelines, including routine vaccination of girls and boys at age 11 or 12 years.
摘要
美国国家健康与营养检查调查（NHANES）收集了人乳头瘤病毒（HPV）疫苗接种史以及性行为方面的信息。我们评估了NHANES的数据，以评估2007 - 2014年期间11至26岁女性和男性中接种≥1剂和3剂HPV疫苗的报告情况。我们还研究了14至26岁女性首次接种疫苗的年龄和首次性行为的年龄。13至26岁女性的疫苗接种率显著上升，但11至12岁女孩的接种率未上升，且女性和男性的接种率均维持在较低水平。在2011 - 2014年的NHANES中，在已知首次接种疫苗年龄的女性中，43.1%报告在接种首剂HPV疫苗之前或同年有过性行为，且这一比例因种族/族裔而异。临床医生应根据指南提供有力建议，包括为11或12岁的女孩和男孩进行常规疫苗接种。
相似文献
1
Human Papillomavirus Vaccination and Age at First Sexual Activity, National Health and Nutrition Examination Survey.
Clin Pediatr (Phila). 2017 Apr;56(4):363-370. doi: 10.1177/0009922816660541. Epub 2016 Oct 1.
2
Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: A population survey-based cross-sectional analysis.
Vaccine. 2020 Dec 14;38(52):8396-8404. doi: 10.1016/j.vaccine.2020.10.033. Epub 2020 Nov 22.
3
Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis.
BMC Med. 2018 Aug 17;16(1):127. doi: 10.1186/s12916-018-1118-3.
4
Human papillomavirus vaccine and sexual behavior among adolescent and young women.
Am J Prev Med. 2012 Jan;42(1):44-52. doi: 10.1016/j.amepre.2011.09.024.
5
Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008.
Prev Med. 2011 May;52(5):398-400. doi: 10.1016/j.ypmed.2010.11.006. Epub 2010 Nov 23.
6
Importance of Lifetime Sexual History on the Prevalence of Genital Human Papillomavirus (HPV) Among Unvaccinated Adults in the National Health and Nutrition Examination Surveys: Implications for Adult HPV Vaccination.
Clin Infect Dis. 2021 May 4;72(9):e272-e279. doi: 10.1093/cid/ciaa1050.
7
Sex of Sexual Partners and Human Papillomavirus Vaccination Among U.S. Girls and Women.
Am J Prev Med. 2016 Mar;50(3):318-327. doi: 10.1016/j.amepre.2015.08.025. Epub 2015 Nov 12.
8
HPV vaccine uptake among overweight and obese US adolescents: An analysis of the National Health and Nutrition Examination Survey (NHANES) 2009-2014.
Vaccine. 2016 May 11;34(22):2501-6. doi: 10.1016/j.vaccine.2016.03.064. Epub 2016 Mar 25.
9
Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014.
J Infect Dis. 2017 Sep 1;216(5):594-603. doi: 10.1093/infdis/jix244.
10
Prevalence of Genital Human Papillomavirus Infection and Human Papillomavirus Vaccination Rates Among US Adult Men: National Health and Nutrition Examination Survey (NHANES) 2013-2014.
JAMA Oncol. 2017 Jun 1;3(6):810-816. doi: 10.1001/jamaoncol.2016.6192.
引用本文的文献
1
Human papillomavirus-related cancers and human papillomavirus vaccination among Arab Americans: A call to unveil disparities and bridge the research gaps.
Cancer. 2025 Apr 1;131(7):e35830. doi: 10.1002/cncr.35830.
2
Urban-rural disparities in cervical cancer screening among Indian women between 30-49 years: a geospatial and decomposition analysis using a nationally representative survey.
BMC Cancer. 2025 Jan 11;25(1):67. doi: 10.1186/s12885-025-13446-z.
3
Vaccine and Non-Vaccine HPV Types Presence in Adolescents with Vertically Acquired HIV Five Years Post Gardasil Quadrivalent Vaccination: The ZIMGARD Cohort.
Viruses. 2024 Jan 22;16(1):162. doi: 10.3390/v16010162.
4
Study on the prevalence and subtypes of human papillomavirus infection among women in the Xuhui District, Shanghai City, China.
Transl Cancer Res. 2023 Oct 31;12(10):2923-2931. doi: 10.21037/tcr-23-1491. Epub 2023 Oct 24.
5
Feminized vaccine? Parents' attitudes toward HPV vaccination of adolescents in Poland: A representative study.
Hum Vaccin Immunother. 2023 Dec 31;19(1):2186105. doi: 10.1080/21645515.2023.2186105. Epub 2023 Mar 22.
6
The Effect of Clinical Decision Prompts in Improving Human Papillomavirus Vaccination Rates in a Multispecialty Practice in a Predominantly Hispanic Population: Quasi-Experimental Study.
JMIR Cancer. 2023 Mar 15;9:e42890. doi: 10.2196/42890.
7
Association between Sexual Activity and Human Papillomavirus (HPV) Vaccine Initiation and Completion among College Students.
Vaccines (Basel). 2022 Dec 5;10(12):2079. doi: 10.3390/vaccines10122079.
8
Analysis of HR-HPV Infection Concordance Rates in Cervical and Urine Specimens; Proposal of Additional Cervical Screening Process for Women Who Refuse Invasive Cervical Sampling.
J Pers Med. 2022 Nov 24;12(12):1949. doi: 10.3390/jpm12121949.
9
Rural-Urban Disparities in HPV Vaccination Coverage Among Adolescents in the Central Part of the State of Illinois, USA.
J Community Health. 2023 Feb;48(1):24-29. doi: 10.1007/s10900-022-01136-x. Epub 2022 Sep 6.
10
Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses.
J Infect Dis. 2022 Sep 28;226(7):1195-1199. doi: 10.1093/infdis/jiac190.
本文引用的文献
1
Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.
MMWR Surveill Summ. 2016 Feb 5;65(1):1-36. doi: 10.15585/mmwr.ss6501a1.
2
Primary Care Physicians' Perspectives About HPV Vaccine.
Pediatrics. 2016 Feb;137(2):e20152488. doi: 10.1542/peds.2015-2488. Epub 2016 Jan 4.
3
Human Papillomavirus Vaccination Coverage Among Girls Before 13 Years: A Birth Year Cohort Analysis of the National Immunization Survey-Teen, 2008-2013.
Clin Pediatr (Phila). 2016 Sep;55(10):904-14. doi: 10.1177/0009922815616245. Epub 2015 Nov 24.
4
Post Approval Human Papillomavirus Vaccine Uptake Is Higher in Minorities Compared to Whites in Girls Presenting for Well-Child Care.
Vaccines (Basel). 2013 Jul 17;1(3):250-61. doi: 10.3390/vaccines1030250.
5
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014.
MMWR Morb Mortal Wkly Rep. 2015 Jul 31;64(29):784-92. doi: 10.15585/mmwr.mm6429a3.
6
ACA Provisions Associated With Increase In Percentage Of Young Adult Women Initiating And Completing The HPV Vaccine.
Health Aff (Millwood). 2015 May;34(5):757-64. doi: 10.1377/hlthaff.2014.1302.
7
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep. 2014 Aug 29;63(RR-05):1-30.
8
Missed opportunities for HPV vaccination in adolescent girls: a qualitative study.
Pediatrics. 2014 Sep;134(3):e666-74. doi: 10.1542/peds.2014-0442.
9
National health and nutrition examination survey: analytic guidelines, 1999-2010.
Vital Health Stat 2. 2013 Sep(161):1-24.
10
Youth risk behavior surveillance--United States, 2013.
MMWR Suppl. 2014 Jun 13;63(4):1-168.
Zotero 插件